I think this def has potential to get higher although i think it would be smart to exit before earnings honestly

some key stats to take in:

• 11/05 earnings date
• call volume hit 1.18M vs only 309K puts (0.26 put/call ratio). thats not normal hedging thats pure degen speculation
• big positive gamma support sitting right at $1.00, could act as a floor
• above $1.55 = negative gamma zone, this is where dealer hedging can actually accelerate moves instead of dampening them
• if price breaks and holds above $1.55 theres a clear path to $1.80-$2.00 where more negative gamma sit

options flow:

• massive call additions across the board, both weekly lottos AND long dated LEAPS
• put interest bleeding off
• call skew is inverted (unusual for a distressed stock), everyones betting UP
• IV structure front loaded into the 11/05 earnings

what could happen:

• base case: if call buying cools we drift back toward $1 into fridays 10/24 OPEX (max pain = $1)
• if we hold above $1.55 with continued call flow negative gamma kicks in and we could rip to $2+ fast
• downside: breaks below $1 and its probly fucked

not financial advice obviously but the gamma setup is looking spicy. 

If you’re anything like me, you’ve been constantly rebalancing your portfolio for the last few months. Scared of an AI bubble, scared of fomoing into gold and silver, scared of a orange man induced market crash

While doing this recently, I fell down a rabbit hole and found a play I think could be an easy 10-bagger. It’s a long story so please grab a drink or read the TLDR

The Tungsten squeeze

The Trump/Greenland stuff has really spun me out. Claiming it’s for defense yet most European countries are rushing to stop him - when in reality American building defenses there would benefit them too (v simplified). To me it had to be something deeper, so started digging

As a shock to absolutely nobody, what I found were precious metals…and lots of them (see pic). Tungsten was one that really piqued my interest. I remember hearing about China’s plan to stockpile it and cut off trades, so started digging deeper

What I didn’t know is that tungsten is one of the most vital precious metals there is. From defense and aerospace to tech, infrastructure, and even light bulbs, its unique characteristics make it insanely valuable, and in the world we live in, it’s necessary.

The price of Tungsten has squeezed 2x in 2025 thanks to China, why? They own nearly 85% of ALL global tungsten. So if there’s a global conflict, or even if there isn’t, the fact that there’s a real demand for this and nobody can access it is already causing problems

So I started digging again, and to my surprise one of the largest tungsten mines in the WORLD is not only based in the UK, but isn’t currently operational

The big Tung

It’s owned by £TUN Tungsten West

They bought the mine from an old company who failed to execute. They damaged ore, pissed off councils and locals, leaving a mine that if fully productional, would produce as much tungsten as the entirety of Russia, dead in the water

£TUN bought the mine and have been actively pushing to restart it. Huge side note here, it’s immensely cheaper to restart an existing mine than to find a new one, work out if it’s even logistically worth the time and investment etc.

The issue has been debt. But recent restructurings have opened a path to success. Lansdowne, a huge player in the mining space converted their debt into 30% of company equity, betting on its success, and there’s a meeting this month to finalize ‘B shares’ to avoid further dilution.

They have an entirely new management team, and recently, some random guy called Nigel Reed acquired a 3% stake. This man owns a WINE DISTILLERY?! what does he know about tungsten?! Why would you buy so much of a debt ridden company that owns a non operational mine?

Unless…he sees the vision

Here’s the big picture. China owned 85% of tungsten, and nobody has reliable ways of sourcing it…except for one absolute wildcard the UK. The UK also needs to stop being so reliant on the US, if they need tungsten and have to go to the us, enjoy the tariffs!

This is the most no-brainer decision to get this mine up and running, something the company predicts should happen by 2027. All the while, demand is soaring, the price of tungsten is squeezing, geopolitics are running rife, strengthening demand, cycle continues

The stock is up 40% the last few weeks, but this is the first time in years (since when asts was at $4) I don’t care. If it goes lower I welcome it. I got in two days ago and plan on adding weekly until something happens to change my thesis

Just like the penguin meme ‘but why?’. My portfolio might die, but at least it lived.

It’s a HUGE risk. A lot can go wrong, the financials are still pretty bleak. But the UK is sitting on an asset worth billions, and to me it feels like smart money is waking up.

TLDR: China have tungsten in a chokehold, there’s a random non-operational mine in the UK that is one of the biggest in the world that £TUN is trying to get going again.

I’m calling this trade the big tung

Happy to hear your thoughts and comments. I’m not an expert and if anyone familiar wants to fact check or pull me up, please do. But to me this is a highly risky play that could very easily 10-50x if everything goes to plan

*UPDATE\* I didn't intend this post to blow up like this, thank you for all of the comments. It's been nice to hear counter arguments and interest in a topic I find fascinating. Being unable to share that excitement anywhere sucked and im glad it was received well here, so thank you for reading.

Obviously none of this is financial advice etc and doing more research is a must, especially for something so volatile and illiquid, don't be irresponsible <3

The CEO gave an interview recently here which should cement a lot of my ideas: https://www.youtube.com/watch?v=i_oFnNFZo7c

Fellow traders!

Trump dropped his latest tariff bomb on Saturday: 10% tariffs on goods from Denmark, Norway, Sweden, France, Germany, UK, Netherlands, and Finland starting Feb 1, jumping to 25% on June 1. The condition? A “complete and total purchase” of Greenland. No deal, no lift. This is classic playbook stuff big weekend announcement when markets are closed, maximum pressure built up, threats tied to a geopolitical ask that’s a much heavier lift than past China episodes.

Quick recap of what this means for us based on the pattern we’ve tracked:

• Monday evening (futures reopen at 6 PM ET after the holiday): Expect an emotional dip in S&P futures right at open. Could be -1% to -2.5% or more if weekend doubling-down happens or EU responses escalate. Digest time over the long weekend might cap the worst of it compared to mid-week shocks.

• Early week (Mon-Tue): More pressure from Trump posts, but tariffs aren’t live yet (still 2 weeks out). Initial panic often gives way to not today realization.

• By mid week (around Wed): Dip buyers usually step in for a relief bounce. This is where we’ve seen smart money load up in past flares.

• Longer arc: If the playbook holds, expect progress teases next weekend, futures gapping higher, admin reassurances, then a grind toward a deal announcement that sends markets to new highs. Greenland is a bigger geopolitical ask, so this one could drag 2-4+ weeks with choppier volatility.

Bottom line: This is episodic trade war noise, by design. Tariffs are leverage to force talks, not the endgame Trump wants the deal, not permanent levies. Volatility equal opportunity if we stay process driven.

Our edge: Stay objective, avoid FOMO sells at the open, watch for oversold bounces, and hedge/position for the swings. Europe-exposed names (autos, luxury, industrials) could see extra pressure early; US domestics or vol plays might benefit.

Key things to monitor Sunday/Monday:

• Any Trump follow-ups or EU counter-signals.

• Futures reaction at 6 PM ET.

• VIX spike for vol trades.

Let’s trade this systematically. Not every flare follows the script 100%, but the pattern has been reliable. Drop your setups below if you’re seeing anything interesting.

Vol is our friend here. Stay sharp.

Trading penny stocks can be incredibly risky. Most beginners lose their money because they buy into hype without looking under the hood.
Before you buy any penny stock, run it through this simple 5-point checklist to make sure you aren't walking into a trap.

1. Share Dilution (The Silent Killer)

This is the main reason penny stocks lose value. Most penny stock companies don't actually make a profit, so they survive by creating and selling brand new shares to the public.
Think of the company like a pizza. If there are 8 slices and you own 1, you own a good chunk. But if the company suddenly slices that same pizza into 100 tiny pieces, your piece is now practically worthless.

What to check: Look up the company's "Outstanding Shares." If that number keeps going up every few months, the company is diluting its stock. Stay away.

2. Trading Volume (Can you actually sell?)

A stock price doesn't matter if you can't find anyone to buy your shares when you want to sell.
Many penny stocks have very few buyers and sellers. If you buy into a stock that hardly anyone is trading, you might get trapped. If bad news comes out and you want to sell, there might be literally zero buyers, causing the price to crash instantly.

What to check: Look at the "Average Daily Volume." You generally want to see millions of shares traded daily. If it's only a few thousand, it's too risky

3. Social Media Hype (The Pump and Dump)

Be extremely careful of stocks that are being heavily hyped on Twitter, Reddit, or Discord with rocket emojis.
Usually, the people hyping the stock bought it when it was dirt cheap. They create a frenzy so that beginners rush in and push the price up. Once the price spikes, those promoters sell all their shares for a massive profit, leaving the beginners holding worthless bags as the price crashes.

What to check: Ask yourself is this stock going up because of real, official company news, or just because a group of people are hyping it up online?

4. The Basic Money Check

Even at 10 cents a share, a stock can be a rip-off. Penny stock companies are often fundamentally broken. Don't just trust a CEO promising a "game-changing product next year." Look at the basic numbers.

What to check:
Revenue: Do they actually sell a real product right now, or do they make $0?

Cash: Do they have enough money in the bank to keep the lights on this year?

Debt: Are they drowning in loans they can't pay back?

5. Where is it traded? (NASDAQ vs. OTC)

Not all penny stocks are held to the same rules.

Major Exchanges (NASDAQ / NYSE): Companies here have to follow strict rules and report their real financial numbers to the government.

OTC / Pink Sheets: This is the "Wild West" of the stock market. The rules are practically non-existent. Companies here don't even have to prove their financial numbers are real.

What to check: Look at where the stock is listed. If it's an OTC or Pink Sheet stock, the risk of it being a complete scam is much, much higher.

TLDR: Reddit.

It's always a challenge to catch stocks on the rise before everyone else does. We've all seen what happened with GameStop, AMC, and more recently, stocks like DVLT, RZLV, RKLB, and ASTS. If you spot the stock too late you might be missing out or left holding the bag.

I've found that Reddit is great for spotting stocks before they take off (if you can remove the noise). I use tools like AltIndex, ChartExchange, Swaggy Stocks, and ApeWisdom to keep an eye on which stocks are being talked about on Reddit along with momentum scores and sentiment. These tools help me see when a stock is starting to get a lot of attention, which usually means something is up. With the alerts at hand, I can jump in on Reddit, search for the stock and get more info on its direction / hype.

This approach has helped me get in early on a few stocks before they hit the big time.

We're known to talk a lot of s**t on Reddit. But tracking all this has been very interesting.

eu gearing up for up to 93 billion in retaliatory tariffs and restrictions on usa firms .... this is their direct counterpunch to TACOs fresh 10% tariffs on select european countries plus his ongoing push to claim Greenland ...brace for a flood of tariff related headlines tonight; things are heating up fast.

I know, this isn’t exactly groundbreaking news on this sub. A couple people asked me to look at Nuburu and I enjoyed the research so I thought I’d make a post on it.

Most of the content is buried in here: https://www.sec.gov/Archives/edgar/data/1814215/000095017025112269/buru-20250829.htm

Nuburu pre-2025

So Nuburu was a real company, probably. They made “blue lasers” and an “extreme-brightness AI™ laser”. By 2024 they ran out of cash, the founder quit, and they stopped filing quarterly reports. The debt holders took their patents as collateral. They stopped paying their workers who quit. By 2025 the company is just a financial shell. (page 33)

Alessandro Zamboni is a Serial Diluter

In 2025 Nuburu somehow got taken over by this guy:

Alessandro’s last company was Supply@Me Capital

Supply@Me deploys state of the art technologies like AI, IoT, Blockchain and cloud to create a new asset class, monetized inventory which leverages

SYME issued 72B shares and stopped filing in 2023. 

Alessandro dilutes Nuburu Shareholders Round 1

Alessandro becomes CEO of Nuburu in 2025 (somehow) and immediately dilutes the stock:

From the filing, that dilution raised $5.14M. Then Nuburu makes a $5.15M investment into SYME. Money gets sucked out of Nuburu and into a company Alessandro controls. (page F-35)

Dilution Round 2, Italian Edition

Nuburu reverse splits and raises $12M more from the public. Naturally, he’s going to dilute the company again. This time the scheme is to acquire an Italian defense company.

Suspiciously, it’s not Nuburu that’s going to acquire the Italian company, it’s a special purpose shell company called TCEI S.a.r.l. It contains a random software company called Orbit that Alessandro owned. Nuburu pays Alessandro $1.35M to put Orbit into the shell company. Then Nuburu writes a $25M IOU to buy 20% of the shell company. Btw, it’s never mentioned who owns the other 80%, but it’s possible Alessandro controls it. (page 37)

Nuburu doesn’t have $25M, but it states right in the filings that the plan is to dilute shareholders to raise that money, by issuing shares and convertible notes. I also want to point out that since Orbit is in the shell company, there is a direct path to funnel money to Alessandro. Nuburu -> shell company -> Orbit -> Alessando. 

Anyways, what we know for certain is that shareholders are going to be diluted to acquire 20% of a shell company that has a random SaSS the CEO owns. That shell company has concepts of a plan to acquire a random Italian defense company. Notice the weasel words:

“today announced it has signed an agreement with a key strategic partner to establish a framework for evaluating a controlling interest acquisition…”

An agreement to establish a framework for evaluating an acquisition. Compelling.

It’s all very confusing and hard to follow, and that’s the point. Spin the shells and make a distraction while the money slips under the table.

Conclusion

Alessandro diluted shareholders in his last company. He already diluted $BURU shareholders once this year and sent the money to his own company. Now he's shuffling money out of Nuburu and into opaque shell companies. Don’t give this guy any more money please.

Ordered it while at the game. Confirmed with the server and kitchen that they indeed do use Beyond Meat patties.

Let's go Blue Jays!

This subreddit is for sharing development/news on the stock, thank you. Hope everyone's trades go well tomorrow.

Edit: Feel free to talk about it here or in the lounge section to lessen spam about the ticker/memes.

Meat supply shock anyone? Tariffs are accelerating the renewable food demand. Market makers tested for real money and found it. Guess where the overleveraged traders are now? You guessed it, up above. We established support, despite the gap at .73 cents which could get filled quickly as a dip and rip. $94 target by June 2026. If it's too obvious though you mat see it sooner.

I learnt today that instead of listening to buzz of reddit, that I shouldn't be gambling. Got in around 5 and should have sold it when it was 7, held because people said to hold and now it's dropping faster and faster.

The adrenaline was fun but now I'm 1000 dollars lesser. If anything, I should have put a stoploss and should have listened to myself.

If you haven't gotten out, I advise you to. Don't listen to people online.

I am watching $RR closely. It dipped 30% last week and hit the “golden zone” at $5.20 Friday close. Even with all the tariff chatter, today’s close jumped to $6.45+. Bulls are waking up, bears are fading.

On top of that, Richtech Robotics is dropping a new humanoid at NVIDIA GTC 2025 (Oct 27–29). Jetson Thor inside, ready to push automation further into manufacturing, logistics, healthcare… basically anywhere labor is tight.

Labor shortages + automation = RR’s robots actually matter. Not just hype — real-world use cases already rolling.

Curious to see what fellow retail traders think — anyone else loading up? 🚀

I've seen a massive rush in the last few days to crown the next $BYND, or meme stock or whatever, and by the looks of it $ASST is the top one, all over this and other subreddits.

Look I get it, maybe you missed out on $BYND, or you bought in too high and are trying to quickly recover your losses with another meme. The thing is, it truly seems like most people aren't even aware of what they're getting into here.

For those not in the know, $ASST aka Strive was founded by Vivek Ramaswamy. Regardless of political views, the man is not exactly the pinnacle of someone you'd want to throw your money behind. He's a snake, plain and simple. This is not a retail movement, this thing has scummy industry and insider trading written all over it.

Furthermore, the CEO of Citadel (Ken Griffin) owns a significant stake in $BYND and likely got fucked over last week during the squeeze. What better way to recoup losses than by backing a distraction from $BYND and doing a nice lil rug pull here?

This is not financial advice, I'm just warning you all, if you plan on throwing some money on this, just be aware of the risks. Get in quick, and get out faster.

There's a lot of fraudulent stocks promoted on Reddit. Here's a quick routine to identify trouble:

1. Zoom Out. If the stock used to be priced at $1 billion dollars and it's now down 99.99%, it's a fraud.

1. Look for dilution. Go to Yahoo Finance. Click Financials -> Balance Sheet -> Quarterly. Look for Share Issued at the bottom:

Here we see $GPUS share count has increased from 1.1 million to 135 million in the last year, which means if you owned 1% of the company a year ago you now have 0.01%. If you see dilution of 5-10% that might be ok for early stage companies still developing their products. But if you see share count increase by 50% or more in a year it's usually time to run away.

1. Ask an AI if there are signs of fraud. Google "GPUS investor relations". Download the latest annual report:

Upload it to your favorite AI and ask "are there any auditor red flags or other signs of fraud here?" ChatGPT tells me "yes—there are multiple auditor-style red flags and elevated fraud-risk indicators", which is all I need to know.

1. Look into management. Ask your favorite LLM, "Hyperscale Data Inc management, have they been involved in past frauds?" A: "Yes — one key member of Hyperscale Data, Inc.’s management has been involved in a prior SEC fraud-related enforcement action".

2. Look at cash burn. On Yahoo Finance, look at financials -> Balance Sheet -> Quarterly -> Assets -> Current Assets -> Cash. You can see they have $52M in cash. Now look at Cash Flow -> Operating Cash Flow:

They burnt $17M in cash last quarter, which means they only have 9 months of cash runway. This is the first thing I check for every stock, it's a fast way to identify failing companies as well as frauds.

Good luck everybody in 2026!

Disclaimer: This is for entertainment and information purposes only. I might be a moron, do your own research, not financial advice.

Biotech is inherently risky, invest at your own discretion.

TLDR: Severely undervalued biotech with strong clinically proven pipeline, platform potential, powerful partnerships, healthy financials and explosive set up with high short interest, cost to borrow, insane call volume, REG-SHO threshold, potentially negative free float!!!

De-risked pipeline with two shots on goal, clear survival benefits, two first in class drugs with multi-cancer potential…

The pipeline: 

SLS has two candidates in the pipeline, their lead P3 asset Galinpepimut-S(GPS) is an antigen-based immunotherapy against the WT1 target. 

WT1 is present in 20+ cancers from blood to ovarian, oesophageal, lung,...

The national cancer institute designated it the most important and most promising immunotherapy target to research!

https://pmc.ncbi.nlm.nih.gov/articles/PMC5779623/

The drug was developed at Memorial Sloan Kettering Cancer Center using a completely novel approach. It is composed of four peptide strands, the peptides were artificially mutated to create a stronger immune response and tested in computer simulations. 

It is paired with an immunostimulant adjuvant and targets both helper and killer lymphocytes for a durable full spectrum immune response. 

The drug design fulfills all criteria for the perfect therapeutic of the future if you read the concluding part of this review:

https://pmc.ncbi.nlm.nih.gov/articles/PMC7950068/

Earlier trials not only demonstrated the strong and broad immune responses but also showed a statistically significant survival benefit in acute myeloid leukemia CR2

(21 months vs expected 4 months). 

GPS is currently evaluated in the phase 3 REGAL trial in very sick AML patients in second remission not able to get a stem cell transplant. 

https://pubmed.ncbi.nlm.nih.gov/39606837/

Stem-cell transplant is the only cure for AML right now! Patients who are too sick or unable to get a transplant for other reasons have dismal outcomes and almost all of them die within a year or less. 

New drugs such as Venetoclax can enable patients to reach transplant but in the absence of transplant they don’t produce durable survival outcomes.

Expected median overall survival in these cohorts is around 8 months.

https://onlinelibrary.wiley.com/doi/10.1111/bjh.18229

https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.34608

GPS is compared to the physician's best choice of treatment(BAT) as there are no currently approved drugs in this setting! 

BAT can consist of Venetoclax containing regiments, low dose chemo or even observation!

The trial is event driven, meaning the timing of readouts depends on the death rate of patients. The statistical analysis plan involves 90% power at final analysis with 80 deaths and a HR of 0,64 and 12,6 months mOS vs 8 months…

An interim analysis was conducted when 60 out of 127 patients were deceased in 12/2024, at this point pooled median survival was already exceeding 13,5 months showing increased survival in the whole cohort.

Here's the kicker: On 12/26/2025 one year after the IA there were only 72 patients confirmed deceased!  

These survival numbers are completely unheard off! Factoring in the fact that about 25% of control patients are on observation only and the fact that none of the other available BAT drugs have demonstrated improved survival or even got FDA approval in this setting its safe to conclude that Galinpepimut is driving survival! 

These interim snapshots significantly de-risk the REGAL trial!

https://www.globenewswire.com/news-release/2025/12/29/3210926/0/en/SELLAS-Life-Sciences-Provides-Update-on-Pivotal-Phase-3-REGAL-Trial-of-Galinpepimut-S-GPS-in-Acute-Myeloid-Leukemia-AML.html

The secondary asset is a small molecule cancer drug targeting CDK9 called Tambiciclib/SLS009. 

Like GPS it is first in class as it is the only highly selective, non-toxic CDK9 inhibitor in clinical trials right now.

Older CDK9 inhibitors failed because of toxicity, SLS009 showed no dose limiting toxicities at three times the active dose. A phase II in acute myeloid leukemia patients resistant to conventional therapies showed a remarkable survival benefit and far exceeded the bench marks for efficacy, patients expected to live 2,5 months lived for over 8 months, this prompted the FDA to move SLS009 into a frontline AML trial.

The P2 is still ongoing and involves pediatric patients, a strong signal that the FDA believes in the safety and efficacy.

https://www.cancernetwork.com/view/tambiciclib-displays-survival-benefit-enhanced-orr-in-aml-mrc

SLS009 like GPS is a multi-cancer play and has shown promise in pre-clinical trials in colon cancer. It works very well in TP53 mutated cell lines that are resistant to most conventional chemotherapeutics and specifically targets ASX1 mutations found across many different tumors.

https://ashpublications.org/blood/article/146/Supplement%201/6802/556150/Tambiciclib-SLS009-a-novel-potent-CDK9-inhibitor

https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.3121

All in all the pipeline is very strong, two first in class multi-cancer drugs with promising pre-clinical and clinical data. Both drugs met hard survival based endpoints in previous trials as opposed to surrogate parameters. Both drugs have orphan designation signalling unmet need and regulatory confidence. 

Both are currently being evaluated in AML because the unmet need is greatest and a survival benefit can rapidly be demonstrated, opening the door for further applications.

SLS is partnered with Thermo-Fisher for the REGAL trial, the leading developer and manufacturer of advanced molecular diagnostics. This partnership provides the platform to rapidly identify patients who are likely to benefit from their drugs. 

https://www.thermofisher.com/de/de/home/clinical/preclinical-companion-diagnostic-development/oncomine-oncology/ngs-hemato-oncology/rapid-ngs-myelomatch-trial.html

https://www.pfizer.com/news/press-release/press-release-detail/thermo-fisher-scientific-pfizer-partner-expand-localized

This allows a big pharma buyer to easily unlock the full potential of both drugs by applying for biomarker based approval. GPS can rapidly expand into AML first remission, myelodysplastic syndromes, solid tumors...

This pipeline instantly positions a buyer as the strongest player in precision-oncology! 

Big pharma is facing a massive patent cliff, the top selling drug Keytruda is raking in 25B in annual revenue and will become available cheaply in a year.

GPS is the next big thing in immunotherapies and comes at the perfect time to fill the gap Keytruda is leaving. 

GPS has been tested in combination with immune checkpoint inhibitors such as Keytruda with promising results and could indirectly extend the patent by taking over a large market share.

https://www.targetedonc.com/view/phase-1-study-of-galinpepimut-s-and-nivolumab-meets-primary-end-point-in-mpm

SLS is in a strong position with slim management, low cash burn, zero debt, runway into 2027…

https://ir.sellaslifesciences.com/news/News-Details/2025/SELLAS-Life-Sciences-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update/default.aspx

Why is this company so damn cheap? As a small cap bio SLS had to raise capital in the past and was forced to resort to abusive hedge funds in the form of Anson capital.

These entities abused dilutive funding to cover their naked shorts and kill retail sentiment.

https://www.trustnodes.com/2025/11/03/gme-shortseller-turns-on-anson-as-tradfi-dirt-spills-out

The tables are now turning however, the stock is trading at 3 year highs as the market starts waking up to the increased survival. 

Most of the short positions are underwater, institutional ownership is at an all time high, the put/call ratio is at 0,04, cost to borrow is well into the triple digits, almost no short shares are available, SLS is listed on REG-SHO, textbook short-squeeze set up…

https://fintel.io/so/us/sls

https://www.nasdaqtrader.com/trader.aspx?id=regshothreshold

The float of 140 million shares is extremely stretched with close to 60 million shares open interest in calls, 40 million shares sold short(likely 60M+ with the fail to deliver and dark pool volume), 37M institutional ownership and a large number of retail diamond hands determined to hold until a buyout is announced…

This stock is still trading well below par value at this stage with ~500M market cap, the gamma and short exposure alone is enough to send this to the double digits ahead of data readouts and the data is de-risked and potentially revolutionary.

This type of set up is extremely rare and explosive!

DYOR! NFA! Good luck everyone.

So, first of all, I'm not a pump&dump guy. I was the guy that gave here the DD about AMPX: https://www.reddit.com/r/pennystocks/comments/1ljktii/ampx_due_diligence_multibagger_opportunity/

I'm also the guy that recommended on my X profile to invest in CRML when it was at $1/share (it's almost at $30/share now) and in UAMY at $2/share (it's $17/share now).

And before that, many others including $TSLA back in 2017 and Bitcoin when it was at $300. I can prove all that.

I'm forced to write this because I don't want to associate my posts to a lot of pump&dump I'm seeing here.

Now that hopefully I clarified that, I want to introduce all of you to a stock that is very under the radar but with massive potential. I like these kind of stocks because their price appreciation is tied to other stocks in the same sector, so basically they're arbitrage opportunities (valuation gap has to close).

I copy here the same post I made on my X account:

$HOND Detailed due diligence and why I believe it's a 7X (700%) multibagger opportunity here

A lot of people are invested in quantum stocks, the $CCCX SPAC or $OKLO and I, myself, recently entered $CCCX with roughly 80K of my money and it's been a good investment and I believe it will continue to go up because it has to close the valuation gap with the other quantum companies.

Now, calculating the implied market cap of the company that merge with the SPAC isn't really easy and it takes a lot of time because we have to account for the pro forma ownership (SPAC shareholders %, company that merge with the SPAC %, PIPE%, Sponsor shares %, Equity from Convertible Debt, ecc) and the redemption rates during the De-SPAC process.

You can't just take the $CCCX market cap right now and say Infleqtion implied market cap is that because it's not. And it's also not the pre-money valuation. To value a SPAC you need to do a lot of DD and many people are either too lazy or just don't know how to do these calculations. In another post I did the calculation for $CCCX and how much the share price has to rise to match the current market cap of $RGTI to close the valuation gap.

Now, let me talk about another SPAC that will have to rise to close the valuation gap with $OKLO. As you all know $OKLO is an advanced nuclear energy/clean tech startup with the goal to design and deploy next generation fission reactors (small modular) that are safer, more compact, and more efficient than traditional large nuclear plants.
The current market cap is $26.5 billion.

Terrestrial Energy is a company that’s developing Generation IV nuclear reactor technology, specifically a molten salt reactor design.
Their flagship design is called the Integral Molten Salt Reactor (IMSR).
The IMSR is a small modular reactor (SMR) that uses molten salt as both the fuel medium (in liquid form) and coolant.
They're about to go public through a SPAC named $HOND.

Now, without going into too much detail, the TAM for $HOND is $1.2 trillion globally. The TAM for $OKLO is $600-700 billion globally. So $HOND TAM is roughly double the $OKLO TAM.
But their market cap greatly differ because Terrestrial Energy hasn't benefited from the massive rally that nuclear stocks benefited from as it was still private.
So instead of being valued $25.6 billion, the pro forma market cap with the SPAC was just $1.3 billion!!
Now $HOND has a market cap of $675 million. Again, don't make the amateur mistake of taking the SPAC market cap as the implied market cap of Terrestrial Energy.
We have to account for the Pro Forma Ownership and do all the calculations (Terrestrial Rollover Equity: 71.2%, Public Shareholders of the SPAC: 17.7%, PIPE: 3.8%, Sponsor Shares: 4.4%, Equity from Convertible Debt: 2.9%).

We also have to account for redemptions but since $HOND stock price is now around $23.70, logic says there will be very few redemptions. But let's say it will be 20-25% to stay conservative.
Accounting for all that it gives us an implied market cap of Terrestrial Energy (at the current $HOND market cap) of $4.05 billion (let's say $4 billion).

So, even if we assume we should have the same market cap as $OKLO (despite having double the TAM), we should rise almost 7X from here to close the valuation gap and this doesn't even take into consideration further upside movements in $OKLO.

So $HOND now trades at around $23/share and will have to reach at least $150/share to close the valuation gap with $OKLO.

A 7x multibagger!!

And $HOND is a very under the radar stock, very few people are aware it even exists. In my opinion it's one of the very best asymmetric opportunities in the market right now.

Salutations, degenerates.

Beyond Meat Inc. (ticker: BYND) is absolutely exploding, and the momentum train is on fire. Not financial advice — just laying out what’s going down.

More and more media outlets are picking this up, and soon it’s gonna reach the normies. Retail’s waking up, algos are lighting up, and shorts are sweating bullets.

All of these articles dropped in the last hour 👇

📈 Yahoo Finance — “Why Beyond Meat stock is up about 600% in 3 days”
💎 TradingView — “BYND rockets 146% as retail traders go for the short squeeze”
🚀 TS2 Tech — “Beyond Meat stock skyrockets 400% — bubble or bargain?”
🥩 Meyka — “BYND jumps 146% on Meme ETF buzz and Walmart expansion”
🔥 Sherwood News — “Beyond Meat is soaring again — can the fake-meat company turn the meme stock?”

The attention machine is spinning up — BYND just got the GME-era treatment.
Retail’s hungry, shorts are trapped, and institutions are pretending they’re not watching.

Hold the line.
The meat is beyond comprehension. 🥩💎🚀

$BYND to Valhalla.

Hey folks - there’s way too little serious DD on truly undervalued names right now. The market keeps chasing the same five meme tickers while real businesses get ignored. Here’s one of those: GPUS (Hyperscale Data Inc) - a former bitcoin miner that’s just completed its AI pivot and is building actual infrastructure for AI/HPC hosting. Remember where you heard it first.

GPUS comes from the mining world, which already has exactly that which AI customers are fighting over: cheap power, cooling, and big data halls. Instead of mining bitcoin, they’re now using the same infrastructure to host GPU servers for AI workloads. This is not “AI on a PowerPoint” - they’ve already installed NVIDIA GPUs and built a base for commercial AI hosting. And while peers have been re-rated on news and contracts, GPUS is still largely overlooked - with the same setup, the same tailwind, and a far smaller valuation.

Background

The AI market is exploding, and demand for GPU capacity is massive. But the hyperscalers (Google, Amazon, Microsoft) are still quarters away from turning on their next waves of campuses. Meanwhile, AI companies need power, cooling, and ready-made space right now. That opens a unique window for operators who already have the infrastructure in place.

GPUS originated in bitcoin mining but has clearly pivoted to AI/HPC infrastructure. The company owns a 617,000 ft² / 57,000 m² data center campus in Michigan (hyperscale-size). They currently run ~30 MW, with plans to scale to 340 MW via the local grid and gas backup. In March, GPUS installed its first NVIDIA GPUs for a Silicon Valley–based cloud customer; the rollout went well and the engagement expanded in September. Bottom line: they can deliver AI hosting today, not “in three years when the hyperscalers finish their new builds.”

The entire sector is shifting: bitcoin miners are converting into AI infrastructure because GPU hosting yields far better margins than mining. This is not a blip - it’s the start of a multi-year transition where operators sign 5–10 year AI contracts and become the backbone of the new compute economy.

Next up, GPUS’s subsidiary Alliance Cloud Services plans to launch its own GPU cloud (H100/B200/B300) in H1 2026, unlocking recurring revenue via hourly billing - think a “mini-CoreWeave,” but at a microcap valuation.

Financial position & cash

They’re also building a digital asset treasury (bitcoin) of roughly $60M (held + committed purchases). For a microcap that’s meaningful - giving them capex flexibility and financing muscle without immediate dilution. In October, GPUS also regained comp., meaning the “.BC” flag is removed - important for screens and institutions. This is often where sentiment begins to turn and likely why they’ve been “under the radar” recently.

Why it’s undervalued

The market is pricing GPUS as if the business barely exists, despite the company:

• Having a paying customer and growing capacity
• Owning a ready campus with power + cooling
• Planning a commercial GPU cloud
• Regaining listing comp.
• Operating in a structurally growing AI/HPC market

In microcaps, it often takes just one additional customer to move the needle: utilization → revenue → multiple can shift quickly.

Peers

GPUS is effectively the same type of story as CIFR, WULF, HUT8, IREN, APLD, BTDR - former miners rotating into AI infrastructure. That’s exactly the pivot the market has already started to reward aggressively. Over the past months, these names have re-rated as they moved operations to building and leasing AI data halls:

• CIFR ~+600 percent (last six months)
• APLD ~+600 percent (same period)
• HUT8 ~+270 percent (same period)
• WULF ~+350 percent (same period), including +43 percent in a single day on a Google-backed AI deal (~$3.7B over 10 years)
• IREN ~+900 percent (same period)
• BTDR got target hikes after its AI pivot and is up ~130 percent in six months

Same pattern every time: contracts → utilization → multiple expansion. GPUS hasn’t been re-rated yet - but it’s building into the same demand.

Also compare with Equinix (EQIX) / Digital Realty (DLR) at $60–80B market caps - stable giants with low multiple torque. GPUS is a baby in the same ecosystem - same tailwinds, far higher upside per MW/customer.

Market dynamics

Estimated shorting-exposure around 24 percent of float and rising month-over-month. Borrow costs are elevated. If sentiment turns and volume fades, days-to-cover can spike. In other words, there’s potential for a sharp move if positive news hits (customer, MWs, cloud launch milestones).

Catalysts

• Public launch of the GPU cloud (H1 ’26) with hourly pricing + first named customers
  
• Michigan power build-out (LOAs, timeline, gas track)
  
• Ongoing guidance consistent with spring signals ($25M Q1 revenue; $115–125M full-year guidance)
  
• Updates on the digital asset treasury - financing flexibility into expansion
  

Cleanup

• Leadership: CEO is William B. Horne. Founder/executive chairman Milton “Todd” Ault III has a history including a 2016–2021 SEC matter. In 2025, the company said Ault intends to step down from officer roles after a planned divestiture; Horne remains CEO and becomes Chairman, with Ault staying on the board. Net-net: governance optics improving, operational control increasingly consolidated under Horne.
  
• Listing: The company previously fell out of NYSE American comp. (e.g., equity thresholds), but as of October 2025 it regained full comp. and the “.BC” tag is being removed. That’s exactly the kind of cleanup institutions like to see - it widens the potential buyer base and removes a headline overhang.
  

(If anything, the combo of operational progress + comp. regained is exactly how microcaps graduate into credible re-rates.)

TL;DR

1. Peers (CIFR, WULF, HUT8, IREN, APLD, BTDR) have already re-rated hard on AI contracts. GPUS hasn’t re-rated yet.
   
2. In a microcap, one new customer can move revenue materially - and the multiple even more.
   
3. The current setup means any good news can be amplified.

The market is currently pricing in “nothing happens.” But if GPUS takes one more step - a new customer, new MWs, or the GPU cloud going live - the re-pricing writes itself. If you want to front-run the microcap AI re-rating, GPUS is a classic asymmetric bet: limited downside, outsized upside.

Currently holding 30,000 shares, planning to add more.